|
| Selecting suitable chemotherapies for PD1/PDL1 blockade to optimize the tumor immune microenvironment |
|
https://doi.org/10.18632/oncotarget.26028
Shohei Koyama, Izumi Nagatomo, Takashi Kijima, and Atsushi Kumanogoh
|
| 32552-32553 |
|
| Balance deficits in longterm pediatric ALL survivors |
|
https://doi.org/10.18632/oncotarget.25967
Mitra Varedi, Kirsten K. Ness, and Raymond F. McKenna
|
| 32554-32555 |
|
| Tumor cell density regulates matrix metalloproteinases for enhanced migration |
|
https://doi.org/10.18632/oncotarget.25863
Hasini Jayatilaka, Fatima G. Umanzor, Vishwesh Shah, Tomer Meirson, Gabriella Russo, Bartholomew Starich, Pranay Tyle, Jerry S.H. Lee, Shyam Khatau, Hava Gil-Henn, and Denis Wirtz
|
| 32556-32569 |
|
| Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated nonmelanoma solid tumors |
|
https://doi.org/10.18632/oncotarget.25948
Lise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, Savvas Kinalis, Ane Y. Schmidt, Kristoffer Staal Rohrberg, Eric Santoni-Rugiu, Finn Cilius Nielsen, Ulrik Lassen, Christina Westmose Yde, Olga Oestrup, and Morten Mau-Sorensen
|
| 32570-32579 |
|
| Chromatin remodeling protein HELLS is upregulated by inactivation of the RBE2F pathway and is nonessential for osteosarcoma tumorigenesis |
|
https://doi.org/10.18632/oncotarget.25953
Stephanie C. Wu, and Claudia A. Benavente
|
| 32580-32592 |
|
| Alendronateinduced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC3 prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25961
Sanna S. Virtanen, Tamiko Ishizu, Jouko A. Sandholm, Eliisa Löyttyniemi, H. Kalervo Väänänen, Johanna M. Tuomela, and Pirkko L. Härkönen
|
| 32593-32608 |
|
| Hematopoietic lineage cellspecific protein 1 HS1 a hidden player in migration invasion and tumor formation is overexpressed in ovarian carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25975
Yoshihiro Koya, Wenting Liu, Yoshihiko Yamakita, Takeshi Senga, Kiyosumi Shibata, Mamoru Yamashita, Akihiro Nawa, Fumitaka Kikkawa, and Hiroaki Kajiyama
|
| 32609-32623 |
|
| Quantitative screening of serum protein biomarkers by reverse phase protein arrays |
|
https://doi.org/10.18632/oncotarget.25976
Zhizhou Kuang, Ruochun Huang, Zhimin Yang, Zhiqiang Lv, Xinyan Chen, Fuping Xu, Yu-Hua Yi, Jian Wu, and Ruo-Pan Huang
|
| 32624-32641 |
|
| Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy |
|
https://doi.org/10.18632/oncotarget.25982
Endang Nuryadi, Yasushi Sasaki, Yoshihiko Hagiwara, Tiara Bunga Mayang Permata, Hiro Sato, Shuichiro Komatsu, Yuya Yoshimoto, Kazutoshi Murata, Ken Ando, Nobuteru Kubo, Noriyuki Okonogi, Yosuke Takakusagi, Akiko Adachi, Mototaro Iwanaga, Keisuke Tsuchida, Tomoaki Tamaki, Shin-ei Noda, Yuka Hirota, Atsushi Shibata, Tatsuya Ohno, Takashi Tokino, Takahiro Oike, and Takashi Nakano
|
| 32642-32652 |
|
| The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis |
|
https://doi.org/10.18632/oncotarget.25987
Kiyoko Takane, Masaki Fukuyo, Keisuke Matsusaka, Satoshi Ota, Bahityar Rahmutulla, Kazuyuki Matsushita, Hideaki Miyauchi, Yukio Nakatani, Hisahiro Matsubara, and Atsushi Kaneda
|
| 32653-32666 |
|
| Involvement of GLUT1mediated glucose transport and metabolism in gefitinib resistance of nonsmallcell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25994
Shuhei Suzuki, Masashi Okada, Hiroyuki Takeda, Kenta Kuramoto, Tomomi Sanomachi, Keita Togashi, Shizuka Seino, Masahiro Yamamoto, Takashi Yoshioka, and Chifumi Kitanaka
|
| 32667-32679 |
|
| Absence of correlation between radiationinduced CD8 Tlymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation |
|
https://doi.org/10.18632/oncotarget.26001
Guillaume Vogin, Jean-Louis Merlin, Alexandra Rousseau, Didier Peiffert, Alexandre Harlé, Marie Husson, Labib El Hajj, Mihai Levitchi, Tabassome Simon, and Jean-Marc Simon
|
| 32680-32689 |
|
| A highthroughput fluorescence polarization assay for discovering inhibitors targeting the DNAbinding domain of signal transducer and activator of transcription 3 STAT3 |
|
https://doi.org/10.18632/oncotarget.26013
Po-Chang Shih, Yiwen Yang, Gary N. Parkinson, Andrew Wilderspin, and Geoffrey Wells
|
| 32690-32701 |
|
| Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.26021
Thomas Prince, Andrew Ackerman, Alice Cavanaugh, Brielle Schreiter, Brendon Juengst, Chaylen Andolino, John Danella, Mitch Chernin, and Heinric Williams
|
| 32702-32717 |
|
| A patientderived orthotopic xenograft model enabling human highgrade urothelial cell carcinoma of the bladder tumor implantation growth angiogenesis and metastasis |
|
https://doi.org/10.18632/oncotarget.26024
Jessie Gills, Ravan Moret, Xin Zhang, John Nelson, Grace Maresh, Linh Hellmers, Daniel Canter, M’Liss Hudson, Shams Halat, Marc Matrana, Michael P. Marino, Jakob Reiser, Maureen Shuh, Eric Laborde, Maria Latsis, Sunil Talwar, Stephen Bardot, and Li Li
|
| 32718-32729 |
|
| Correction: Mechanosensitive caveolin1 activationinduced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility invadopodia formation and metastasis in vivo |
|
https://doi.org/10.18632/oncotarget.26065
Hong Yang, Liuyuan Guan, Shun Li, Ying Jiang, Niya Xiong, Li Li, Chunhui Wu, Hongjuan Zeng, and Yiyao Liu
|
| 32730-32730 |
|
| Correction: SEL1L SNP rs12435998 a predictor of glioblastoma survival and response to radiochemotherapy |
|
https://doi.org/10.18632/oncotarget.26066
Marta Mellai, Monica Cattaneo, Alessandra Maria Storaci, Laura Annovazzi, Paola Cassoni, Antonio Melcarne, Pasquale De Blasio, Davide Schiffer, and Ida Biunno
|
| 32731-32731 |
